The effects of genetic and pharmacological blockade of the CB1 cannabinoid receptor on anxiety

Unresponsiveness to Cannabinoids and Reduced Addictive Effects of Opiates in CB 1 Receptor Knockout Mice

Ledent, C. A., Valverde, O., Cossu, G., Petitet, F., Aubert, J.-F., Beslot, F., Böhme, G. A., Impérato, A., Pedrazzini, T., Roques, B. P., et al. (1999) · Science · doi:10.1126/science.283.5400.401 · Cited by 3,628

A review of the validity and variability of the Elevated Plus-Maze as an animal model of anxiety

Hogg, S. (1996) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(95)02126-4 · Cited by 1,169

Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice

Zimmer, A., Zimmer, A. M., Hohmann, A. G., Herkenham, M. A., & Bonner, T. I. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5780 · Cited by 1,078

Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors

Járai, Z., Wagner, J. A., Varga, K., Lake, K. D., Compton, D. M., Martin, B. R., Zimmer, A. M., Bonner, T. I., Buckley, N. E., Mezey, É., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.24.14136 · Cited by 597

Evidence for a New G Protein-Coupled Cannabinoid Receptor in Mouse Brain

Breivogel, C. S., Griffin, G., Marzo, V. D., & Martin, B. R. (2001) · Molecular Pharmacology · doi:10.1124/mol.60.1.155 · Cited by 538

Involvement of CB1 cannabinoid receptors in emotional behaviour

Martín, M., Ledent, C. A., Parmentier, M., Maldonado, R. J., & Valverde, O. (2002) · Psychopharmacology · doi:10.1007/s00213-001-0946-5 · Cited by 525

Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus

Hájos, N., Ledent, C. A., & Freund, T. F. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00287-1 · Cited by 421

Levels, Metabolism, and Pharmacological Activity of Anandamide in CB1 Cannabinoid Receptor Knockout Mice

Marzo, V. D., Breivogel, C. S., Tao, Q., Bridgen, D. T., Razdan, R. K., Zimmer, A. M., Zimmer, A., & Martin, B. R. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0752434.x · Cited by 394

In vivo characterization of a specific cannabinoid receptor antagonist (SR141716A): inhibition of delta 9-tetrahydrocannabinol-induced responses and apparent agonist activity.

Compton, D. M., Aceto, M. D. G., Lowe, J. A., III, & Martin, B. R. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12911-x · Cited by 357

Pharmacological characterization of cannabinoids in the elevated plus maze.

Onaivi, E. S., Green, M. R., & Martin, B. R. (1990) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)13195-9 · Cited by 312

Intracerebroventricular administration of cannabinoid CB1 receptor antagonists AM251 and AM4113 fails to alter food-reinforced behavior in rats

Sink, K. S., Segovia, K. N., Nunes, E. J., Collins, L. E., Vemuri, K. V., Thakur, G. A., Makriyannis, A., & Salamone, J. D. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1602-8 · Cited by 28

κ‐ and δ‐opioid receptor functional activities are increased in the caudate putamen of cannabinoid CB1receptor knockout mice

Urigüen, L., Berrendero, F., Ledent, C. A., Maldonado, R. J., & Manzanares, J. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04372.x · Cited by 25

Brain endocannabinoid signaling exhibits remarkable complexity

Gorzkiewicz, A., & Szemraj, J. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2018.06.012 · Cited by 26

Inhibition of fatty acid amide hydrolase by URB597 attenuates the anxiolytic-like effect of acetaminophen in the mouse elevated plus-maze test

Zaitone, S. A., El-Wakeil, A. F., & Abou‐El‐Ela, S. H. (2012) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e3283566065 · Cited by 24

The Cannabinoid CB1 Antagonist TM38837 With Limited Penetrance to the Brain Shows Reduced Fear-Promoting Effects in Mice

Micale, V., Drago, F., Nørregaard, P. K., Elling, C., & Wotjak, C. T. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00207 · Cited by 24

Le système endocannabinoïde central

Venance, L., Maldonado, R., & Manzoni, O. J. (2004) · médecine/sciences · doi:10.1051/medsci/200420145 · Cited by 24

Decreased GABA A and GABA B receptor functional activity in cannabinoid CB 1 receptor knockout mice

Urigüen, L., García‐Gutiérrez, M. S., & Manzanares, J. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881109358204 · Cited by 24

Diacylglycerol lipase alpha in astrocytes is involved in maternal care and affective behaviors

Schüle, L., Glasmacher, S., Gertsch, J., Roggan, M. D., Transfeld, J. L., Bîndilă, L., Lutz, B., Kolbe, C., Bilkei‐Gorzó, A., Zimmer, A., et al. (2020) · Glia · doi:10.1002/glia.23903 · Cited by 25

Neuropeptide receptors as potential pharmacological targets for obesity

Meneguetti, B. T., Cardoso, M. H. E. S., Ribeiro, C. F. A., Felício, M. R., Pinto, I. B., Santos, N. C., Carvalho, C. M. E., & Franco, O. L. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.11.002 · Cited by 23

Sex and cannabinoid CB1 genotype differentiate palatable food and cocaine self-administration behaviors in mice

Ward, S. J., & Walker, E. A. (2009) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e328331ba30 · Cited by 22

The CB 1Receptor Antagonist, AM 281, Improves Recognition Loss Induced by Naloxone in Morphine Withdrawal Mice

Vaseghi, G., Rabbani, M., & Hajhashemi, V. (2012) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2012.00881.x · Cited by 22

Effects of the fatty acid amide hydrolase inhibitor URB597 on coping behavior under challenging conditions in mice

Haller, J., Aliczki, M., Gyimesi-Pelczer, K., Spitzer, K., Balogh, Z., & Kántor, S. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3273-8 · Cited by 22

Low dosage of rimonabant leads to anxiolytic-like behavior via inhibiting expression levels and G-protein activity of kappa opioid receptors in a cannabinoid receptor independent manner

Zádor, F., Lénárt, N., Csibrány, B., Sántha, M., Molnar, M. F., Tuka, B., Samavati, R., Klivènyi, P., Vécsei, L., Marton, A., et al. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.10.008 · Cited by 21

Effects of CB1 receptor antagonism and stress exposures in adolescence on socioemotional behaviours, neuroendocrine stress responses, and expression of relevant proteins in the hippocampus and prefrontal cortex in rats

Simone, J. J., Baumbach, J. L., & McCormick, C. M. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.10.029 · Cited by 21

Neuropeptide Y and cannabinoids interaction in the amygdala after exposure to shock and reminders model of PTSD

Maymon, N., Zer‐Aviv, T. M., Sabban, E. L., & Akirav, I. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.107804 · Cited by 21

WIN-55,212-2 chronically implanted into the CA3 region of the dorsal hippocampus impairs learning: a novel method for studying chronic, brain-area-specific effects of cannabinoids

Barna, I., Soproni, K., Arszovszki, A., Csabai, K., & Haller, J. (2007) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e3282d9e9f9 · Cited by 21

Anxiety-like effects of SR141716-precipitated delta9-tetrahydrocannabinol withdrawal in mice in the elevated plus-maze

Huang, P., Liu‐Chen, L., & Kirby, L. G. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.03.071 · Cited by 21

N-ethyl-N-nitrosourea mouse mutants in the dissection of behavioural and psychiatric disorders

Keays, D. A., & Nolan, P. M. (2003) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2003.08.107 · Cited by 21

Prenatal ethanol exposure causes anxiety-like phenotype and alters synaptic nitric oxide and endocannabinoid signaling in dorsal raphe nucleus of adult male rats

Oubraim, S., Wang, R., Hausknecht, K. A., Kaczocha, M., Shen, R., & Haj‐Dahmane, S. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-02210-7 · Cited by 21

CB1-independent mechanisms of Δ9-THCV, AM251 and SR141716 (rimonabant)

Raffa, R. B., & Ward, S. J. (2011) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/j.1365-2710.2011.01284.x · Cited by 21

Assessment of the abuse potential of MDMA in the conditioned place preference paradigm: Role of CB1 receptors

Rodríguez‐Arias, M., Valverde, O., Daza‐Losada, M., Blanco-Gandía, M. C., Aguilar, M. A., & Miñarro, J. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.07.013 · Cited by 20

Chronic unpredictable stress enhances cocaine-conditioned place preference in type 1 cannabinoid receptor knockout mice

Miller, L. L., Ward, S. J., & Dykstra, L. (2008) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32830ded11 · Cited by 21

Cannabinoids in Health and Disease

Meccariello, R., & Chianese, R. (2016) · InTech eBooks · doi:10.5772/61595 · Cited by 22

Focusing on the Possible Role of the Cerebellum in Anxiety Disorders

Meghan, D., & Richard, J. (2013) · InTech eBooks · doi:10.5772/52954 · Cited by 20

Anxiolytic and antidepressive effects of electric stimulation of the paleocerebellar cortex in pentylenetetrazol kindled rats

Godlevsky, L. S., Муратова, Т. М., Kresyun, N. V., van Luijtelaar, G., & Coenen, A. M. L. (2014) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-2014-2008 · Cited by 21

Adolescent exposure to nicotine alters the aversive effects of cocaine in adult rats

Hutchison, M. A., & Riley, A. L. (2008) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2008.04.004 · Cited by 18

Endocannabinoid signaling and epigenetics modifications in the neurobiology of stress-related disorders

Coelho, A. A., Bastos, S., Gobira, P. H., & Lisboa, S. F. D. S. (2023) · Neuronal Signaling · doi:10.1042/ns20220034 · Cited by 22

Pre-training anandamide infusion within the basolateral amygdala impairs plus-maze discriminative avoidance task in rats

Munguba, H., Cabral, A. E. A., Leão, A. H. F. F., Barbosa, F. F., Izídio, G. S., Ribeiro, A. M., & Silva, R. H. (2011) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2011.03.006 · Cited by 19

Effect of WIN55-212-2 and Consequences of Extinction Training on Conditioned Fear Memory in PTSD Male Rats

Ghasemi, M., Abrari, K., Goudarzi, I., & Rashidy‐Pour, A. (2017) · Basic and Clinical Neuroscience Journal · doi:10.29252/nirp.bcn.8.6.493 · Cited by 19

Pharmacological inhibition of the primary endocannabinoid producing enzyme, DGL ‐α, induces autism spectrum disorder‐like and co‐morbid phenotypes in adult C57BL /J mice

Fyke, W., Alarcón, J. M., Velinov, M. T., & Chadman, K. K. (2021) · Autism Research · doi:10.1002/aur.2520 · Cited by 19

Behavioral Responses to Acute and Sub-chronic Administration of the Synthetic Cannabinoid JWH-018 in Adult Mice Prenatally Exposed to Corticosterone

Macrı̀, S., Lanuzza, L., Merola, G., Ceci, C., Gentili, S., Valli, A., Macchia, T., & Laviola, G. (2013) · Neurotoxicity Research · doi:10.1007/s12640-012-9371-2 · Cited by 19

Cat odour-induced anxiety—a study of the involvement of the endocannabinoid system

Sütt, S., Raud, S., Areda, T., Reimets, A., Kõks, S., & Vasar, E. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0927-4 · Cited by 22

Evidence for a Role of Adolescent Endocannabinoid Signaling in Regulating HPA Axis Stress Responsivity and Emotional Behavior Development

Lee, T. T.-Y., & Gorzalka, B. B. (2015) · International review of neurobiology · doi:10.1016/bs.irn.2015.09.002 · Cited by 22

Sex‐specific effects of CB1 receptor antagonism and stress in adolescence on anxiety, corticosterone concentrations, and contextual fear in adulthood in rats

Simone, J. J., Baumbach, J. L., & McCormick, C. M. (2018) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2018.07.011 · Cited by 18

The effects of infusions of CART 55–102 into the basolateral amygdala on amphetamine-induced conditioned place preference in rats

Rademacher, D. J., Sullivan, E. M., & Figge, D. A. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1748-4 · Cited by 18

The endocannabinoid gene faah2a modulates stress-associated behavior in zebrafish

Krug, R. G., Lee, H. B., Khoury, L. Y. E., Sigafoos, A. N., Petersen, M. O., & Clark, K. J. (2018) · PLoS ONE · doi:10.1371/journal.pone.0190897 · Cited by 18

Genetic deletion of CB1 receptors improves non-associative learning

Degroot, A., Salhoff, C. R., Davis, R. J., & Nomikos, G. G. (2005) · Behavioural Brain Research · doi:10.1016/j.bbr.2005.02.018 · Cited by 18

Cannabis use and posttraumatic stress disorder comorbidity: Epidemiology, biology and the potential for novel treatment approaches

Kondev, V., Winters, N. D., & Patel, S. (2021) · International review of neurobiology · doi:10.1016/bs.irn.2020.09.007 · Cited by 21

Rational Design of Novel Peptidic DnaK Ligands

Liebscher, M., Haupt, K., Yu, C., Jahreis, G., Lücke, C., & Schiene‐Fischer, C. (2010) · ChemBioChem · doi:10.1002/cbic.201000166 · Cited by 17

Behavioural and pharmacological characterization of a novel cannabinomimetic adamantane-derived indole, APICA, and considerations on the possible misuse as a psychotropic spice abuse, in C57bl/6J MICE

Cannizzaro, C., Malta, G., Argo, A., Brancato, A., Roda, G., Casagni, E., Fumagalli, L., Valoti, E., Froldi, R., Procaccianti, P., et al. (2016) · Forensic Science International · doi:10.1016/j.forsciint.2015.12.035 · Cited by 17

Double‐blind placebo controlled trial of the anxiolytic effects of a standardized Echinacea extract

Haller, J., Krecsák, L., & Zámbori, J. (2019) · Phytotherapy Research · doi:10.1002/ptr.6558 · Cited by 17

α-Tocopherol and α-tocopheryl phosphate interact with the cannabinoid system in the rodent hippocampus

Crouzin, N., Ferreira, M. D. J., Cohen‐Solal, C., M’Kadmi, C., Bernad, N., Martínez, J., Barbanel, G., Vignes, M., & Guiramand, J. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.07.012 · Cited by 17

Interaction Between the Cannabinoid and Vanilloid Systems on Anxiety in Male Rats

Faraji, N., Komaki‬, A., & Salehi, I. (2017) · Basic and Clinical Neuroscience Journal · doi:10.18869/nirp.bcn.8.2.129 · Cited by 16

Anxiety Modulation by Cannabinoids—The Role of Stress Responses and Coping

Haller, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242115777 · Cited by 17

Chapter 7 Cannabinoid Receptor CB1 Antagonists

Bifulco, M., Santoro, A., Laezza, C., & Malfitano, A. M. (2009) · Vitamins and hormones · doi:10.1016/s0083-6729(09)81007-8 · Cited by 16

Co-localization of the cannabinoid type 1 receptor with corticotropin-releasing factor-containing afferents in the noradrenergic nucleus locus coeruleus: implications for the cognitive limb of the stress response

Wyrofsky, R. R., Reyes, B. A. S., & Bockstaele, E. J. V. (2017) · Brain Structure and Function · doi:10.1007/s00429-017-1381-7 · Cited by 15

Effects of 2-AG on the reinforcing properties of wheel activity in obese and lean Zucker rats

Smith, S. L., & Rasmussen, E. B. (2010) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32833aec4d · Cited by 15

The effect of BLA GABAA receptors in anxiolytic-like effect and aversive memory deficit induced by ACPA

Haghighi, K. K., Oryan, S., Nasehi, M., & Zarrindast, M. (2015) · EXCLI journal · doi:10.17179/excli2015-201 · Cited by 14

Cannabis Use and Psychiatric Disorders: Implications for Mental Health and Addiction Treatment

Halah, M. P., Zochniak, M. P., Barr, M. S., & George, T. P. (2016) · Current Addiction Reports · doi:10.1007/s40429-016-0128-5 · Cited by 13

Effect of repeated juvenile exposure to Δ9‑tetrahydrocannabinol on anxiety-related behavior and social interactions in adolescent rats

Mohammed, A. N., Alugubelly, N., Kaplan, B. L. F., & Carr, R. L. (2018) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2018.06.003 · Cited by 13

URB597 abrogates anxiogenic and depressive behaviors in the methamphetamine-withdrawal mice: Role of the cannabinoid receptor type 1, cannabinoid receptor type 2, and transient receptor potential vanilloid 1 channels

Ebrahimi-Ghiri, M., Khakpai, F., & Zarrindast, M. (2020) · Journal of Psychopharmacology · doi:10.1177/0269881120965934 · Cited by 13

Sex differences in cocaine-associated memory: The interplay between CB1, mGluR5, and estradiol

Chang, H.-A., Dai, W., & Hu, S. S. (2021) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2021.105366 · Cited by 13

Genetic dissection of anxiety in autoimmune disease

Nakamura, K. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg128 · Cited by 13

Introduction to the special issue on stress, emotional behavior, and the endocannabinoid system: a decade of research

Hill, M. N. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.01.038 · Cited by 14

Genetic Models of the Endocannabinoid System

Monory, K., & Lutz, B. (2009) · Current topics in behavioral neurosciences · doi:10.1007/978-3-540-88955-7_5 · Cited by 12

The effects of chronic administration of tranylcypromine and rimonabant on behaviour and protein expression in brain regions of the rat

Assareh, N., ElBatsh, M. M., Marsden, C. A., & Kendall, D. A. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.10.017 · Cited by 12

Role of Cannabinoid Receptors in Anxiety Disorders

Degroot, A. (2007) · Springer eBooks · doi:10.1007/978-0-387-74349-3_24 · Cited by 12

Evaluation of anxiety-related behavior in elevated plus-maze test and its applications

Yamaguchi, T., Togashi, H., Matsumoto, M., & Yoshioka, M. (2005) · Folia Pharmacologica Japonica · doi:10.1254/fpj.126.99 · Cited by 12

Cortical adrenoceptor expression, function and adaptation under conditions of cannabinoid receptor deletion

Reyes, B. A. S., Carvalho, A. F., Szot, P., Kalamarides, D. J., Wang, Q., Kirby, L. G., & Bockstaele, E. J. V. (2017) · Experimental Neurology · doi:10.1016/j.expneurol.2017.03.010 · Cited by 12

An investigation into the anxiety-relieving and mood-enhancing effects of Echinacea angustifolia (EP107™): A randomised, double-blind, placebo-controlled study

Lopresti, A. L., & Smith, S. J. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.06.054 · Cited by 11

Bed nucleus of the stria terminalis CB1 receptors and the FAAH enzyme modulate anxiety behavior depending on previous stress exposure

Borges‐Assis, A. B., Uliana, D. L., Hott, S. C., Guimarães, F. S., Lisboa, S. F. D. S., & Resstel, L. B. M. (2023) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2023.110739 · Cited by 11

Targeting the endocannabinoid system to treat haunting traumatic memories

Akirav, I. (2013) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2013.00124 · Cited by 11

The genetic versus pharmacological invalidation of the cannabinoid CB1 receptor results in differential effects on ‘non-associative’ memory and forebrain monoamine concentrations in mice

Thiemann, G., Fletcher, B. C., Ledent, C. A., Molleman, A., & Hasenöhrl, R. U. (2007) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2007.07.013 · Cited by 11

Neurobiology of Anxiety

Tóth, M., & Zupan, B. (2007) · Wiley eBooks · doi:10.1002/9780470101001.hcn023 · Cited by 12

The Effects of Indirect and Direct Modulation of Endocannabinoid System Function on Anxiety-Related Behavior in Mice Assessed in the Elevated Plus Maze Test

Kruk-Słomka, M., Dzik, A., & Biała, G. (2025) · Molecules · doi:10.3390/molecules30040867 · Cited by 10

The Endocannabinoid System in Prefrontal Synaptopathies

Scheyer, A. F., Martin, H. G. S., & Manzoni, O. J. (2017) · Springer eBooks · doi:10.1007/978-3-319-57371-7_7 · Cited by 10

Circuit mechanisms governing endocannabinoid modulation of affective behaviour and stress adaptation

Loomba, N., & Patel, S. (2025) · Nature reviews. Neuroscience · doi:10.1038/s41583-025-00961-y · Cited by 11

Endocannabinoid Signaling in Neural Circuits of the Olfactory and Limbic System

Heinbockel, T., Wang, Z., Brown, E. A., & Austin, P. T. (2016) · InTech eBooks · doi:10.5772/63214 · Cited by 9

Repeated Mild Traumatic Brain Injury and JZL184 Produce Sex-Specific Increases in Anxiety-Like Behavior and Alcohol Consumption in Wistar Rats

Jacotte-Simancas, A., Molina, P. E., & Gilpin, N. W. (2023) · Journal of Neurotrauma · doi:10.1089/neu.2023.0088 · Cited by 8

The effect of AM281, a cannabinoid antagonist, on memory performance during spontaneous morphine withdrawal in mice.

Vaseghi, G., Rabbani, M., & Hajhashemi, V. (2013) · Europe PMC (PubMed Central) · Cited by 8

Chapter 4.5 The endocannabinoid system and anxiety responses

Bortolato, M., & Piomelli, D. (2008) · Handbook of Behavioral Neuroscience · doi:10.1016/s1569-7339(07)00014-8 · Cited by 7

Perinatal omega-3 sex-selectively mitigates neuropsychiatric impacts of prenatal THC in the cortico-striatal-hippocampal circuit

Sarikahya, M. H., Cousineau, S. L., Felice, M. D., Szkudlarek, H. J., Lee, K., Doktor, A., Alcaide, A., DeVuono, M. V., Dembla, A., Wong, K., et al. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03113-x · Cited by 9

Effects of cannabidiol on fear conditioning in anxiety disorders: decreased threat expectation during retention, but no enhanced fear re-extinction

Kwee, C., van der Flier, F. E., Duits, P., van Balkom, A. J. L. M., Cath, D. C., & Baas, J. M. P. (2023) · Psychopharmacology · doi:10.1007/s00213-023-06512-6 · Cited by 7

CB1 receptor signaling: Linking neuroplasticity, neuronal types, and mental health outcomes

Gao, Q., & Asim, M. (2025) · Neurochemistry International · doi:10.1016/j.neuint.2025.105938 · Cited by 6

Lifestyle Interventions Improving Cannabinoid Tone During COVID-19 Lockdowns May Enhance Compliance With Preventive Regulations and Decrease Psychophysical Health Complications

Brugnatelli, V., Facco, E., & Zanette, G. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.565633 · Cited by 6

Cannabidiol effect in pentylenetetrazole-induced seizures depends on PI3K

Lima, I. V. D. A., Pinto, H. P. P., Bellozi, P. M. Q., da Silva, M. C. M., Vilela, L., Moreira, F. A., Moraes, M. F. D., & de Oliveira, A. C. P. (2022) · Pharmacological Reports · doi:10.1007/s43440-022-00391-y · Cited by 6

Pharmacological comparison of traditional and non-traditional cannabinoid receptor 1 blockers in rodent models in vivo

Varga, B., Kassai, F., Szabó, G., Kovács, P., Fischer, J., & Gyertyán, I. (2017) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2017.06.012 · Cited by 6

An Amygdala‐hippocampus Circuit for Endocannabinoid Modulation of Anxiety Avoidance

Xue, B., Zhang, M., Bi, X., Lai, S., Bie, X., Dong, Y., Li, J., Gao, F., Zhang, X., & Wang, Y. (2025) · Advanced Science · doi:10.1002/advs.202505121 · Cited by 5

Imaging and Genetic Tools for the Investigation of the Endocannabinoid System in the CNS

Kouchaeknejad, A., van der Walt, G., de Donato, M. H., & Puighermanal, E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242115829 · Cited by 6

Different effects of chronic THC on the neuroadaptive response of dopamine D2/3 receptor‐mediated signaling in roman high‐ and roman low‐avoidance rats

Tournier, B. B., Dimiziani, A., Tsartsalis, S., Millet, P., & Ginovart, N. (2017) · Synapse · doi:10.1002/syn.22023 · Cited by 5

Tıbbi Esrar Psikiyatrik Bozuklukların Tedavisinde Kullanılabilir mi?

Tellioğlu, T., & Tellioğlu, Z. (2012) · Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology · doi:10.5455/bcp.20120223123828 · Cited by 5

Interactions Between Cannabinoid Signaling and Anxiety: A Comparative Analysis of Intervention Tools and Behavioral Effects

Aliczki, M., & Haller, J. (2015) · Springer eBooks · doi:10.1007/978-1-4939-2294-9_4 · Cited by 5

Cognitive Enhancers in Exposure Therapy for Anxiety and Related Disorders

Hofmann, S. G., Gutner, C. A., & Asnaani, A. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3342-2_6 · Cited by 3

Cb1 receptor-mediated signaling emerges as a novel lead to evidence-based treatment development for stress-related psychopathology

Bailey, C. R., & Neumeister, A. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.07.011 · Cited by 4

Endocannabinoid Signaling in Reward and Addiction: From Homeostasis to Pathology

Laredo, S. A., Marrs, W., & Parsons, L. H. (2017) · Springer eBooks · doi:10.1007/978-3-319-57371-7_10 · Cited by 5

Cannabinoid-Alcohol Interactions

Natividad, L. A., Maccioni, P., Parsons, L. H., & Colombo, G. (2015) · Springer eBooks · doi:10.1007/978-1-4939-2294-9_14 · Cited by 4

The role of the endocannabinoid system in managing neuropsychiatric symptoms in Alzheimer’s disease

Rao, J. S., Tangarife, M. A., Venegas, M., Forero, B., Tamayo, L. L. G., Escobar-Gallego, J. P., Rodríguez‐Soacha, D. A., Ferreirós, A., & Mukunda, R. (2026) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1709266 · Cited by 5

Neostriatum neuronal TRPV1-signalling mediates striatal anandamide at high concentration facilitatory influence on neostriato-nigral dishinhibitory GABAergic connections

da Silva, J. A., Almada, R. C., Falconi‐Sobrinho, L. L., Pigatto, G. R., Hernandes, P. M., & Coimbra, N. C. (2022) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2022.11.014 · Cited by 3

Behavioral Studies of p62 KO Animals with Implications of a Modulated Function of the Endocannabinoid System

Keller, C., Rading, S., Bîndilă, L., & Karsak, M. (2022) · Cells · doi:10.3390/cells11091517 · Cited by 3

The function of the endocannabinoid system

Cascio, M. G., & Pertwee, R. G. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9780511706080.004 · Cited by 3

Genetic dissection of the endocannabinoid system and how it changed our knowledge of cannabinoid pharmacology and mammalian physiology

Lutz, B. (2014) · Wiley eBooks · doi:10.1002/9781118451281.ch4 · Cited by 3

Herbal Cannabis and Depression: A Review of Findings Published over the Last Three Years

Haller, J. (2024) · Pharmaceuticals · doi:10.3390/ph17060689 · Cited by 2

Electroacupuncture alleviates chronic stress-induced anxiety via excitatory neuron CB1 receptor-dependent suppression of GR/SGK1 signaling in the mPFC

Hu, X.-F., Zhang, L.-J., Lin, Q., Ge, W., Ren, H., Zhu, S.-X., & Li, M. (2026) · Journal of Affective Disorders · doi:10.1016/j.jad.2026.121242 · Cited by 2

Interaction of GABA (A) system in the nucleus accumbens ahell with ACPA on anxiety-like behaviors in Wistar male rat

Zarrindast, M., Ahmadi, H., & Nasehi, M. (2013) · Journal of Experimental and Applied Animal Sciences · doi:10.20454/jeaas.2013.707 · Cited by 2

Neonatal dysregulation of 2-arachidonoylglycerol induces impaired brain function in adult mice

Boo, K.-J., Kim, D., Cho, E., Kim, D. H., Jeon, S. J., & Shin, C. Y. (2024) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.110045 · Cited by 2

Bridging the gap: The endocannabinoid system as a functional fulcrum for benzodiazepines in a novel frontier of anxiety pharmacotherapy

Pakkhesal, S., Shakouri, M., Mosaddeghi-Heris, R., Kiani-Nasab, S., Salehi, N., Sharafi, A., & Ahmadalipour, A. (2025) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2025.108799 · Cited by 3

Stress reactivity is modulated by cannabinoid type-1 receptors in norepinephrine and epinephrine neurons in a context-dependent manner

Engborg, C. B., Pujar, M., Kanadia, R., & Sciolino, N. R. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.08.046 · Cited by 2

Effects of Different Cannabinoid Formulations on Anxiety-Related Disorders, and Tourette Syndrome: A Systematic Review and Meta-Analysis

Raminelli, A. O., Simei, J. L. Q., Guimarães, F. S., Zuardi, A. W., Hallak, J. E. C., Crippa, J. A. S., & Osório, F. L. (2025) · Cannabis and Cannabinoid Research · doi:10.1177/25785125251378242 · Cited by 2

Cannabinoids and their medicinal potential

Tikoo, D., Sharma, G., & Gupta, M. (2012) · International Journal of Basic & Clinical Pharmacology · doi:10.5455/2319-2003.ijbcp001512 · Cited by 2

Potential use of cannabimimetics in the treatment of cancer

PETROCELLIS, L. D., Bifulco, M., Ligresti, A., & Marzo, V. D. (2005) · Birkhäuser Basel eBooks · doi:10.1007/3-7643-7358-x_9 · Cited by 2

CB1 cannabinoid receptors mediate anxiolytic effects: convergent genetic and pharmacological evidence with CB1-specific agents

Haller, J., Varga, B., Ledent, C., & Freund, T. F. (2004) · Behavioural Pharmacology · doi:10.1097/01.fbp.0000135704.56422.40 · Cited by 241

Modulation of anxiety by acute blockade and genetic deletion of the CB1 cannabinoid receptor in mice together with biogenic amine changes in the forebrain

Thiemann, G., Watt, C. A., Ledent, C. A., Molleman, A., & Hasenöhrl, R. U. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.12.035 · Cited by 44

Genetic deletion and pharmacological blockade of CB1 receptors modulates anxiety in the shock‐probe burying test

Degroot, A., & Nomikos, G. G. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03556.x · Cited by 58

‘One‐trial sensitization’ to the anxiolytic‐like effects of cannabinoid receptor antagonist SR141716A in the mouse elevated plus‐maze

Rodgers, R. J., Haller, J., Halász, J., & Mikics, É. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02548.x · Cited by 88

Acute administration of the CB1 cannabinoid receptor antagonist SR 141716A induces anxiety-like responses in the rat

Navarro, M., Hernández, E., Muñoz, R. M., del Arco, I., Villanúa, M. Á., Carrera, M. R. A., & de Fonseca, F. R. (1997) · Neuroreport · doi:10.1097/00001756-199701200-00023 · Cited by 306